(SAGE) A study measuring the impact of pharmaceutical commercial operations on company performance finds that strategic investment in commercial innovation linked with an aligned and responsive culture of execution can produce positive results. The study, 'What Makes More Better? An Exploratory Study on the Effects of Firm-Level Commercial Operations Attributes on Pharmaceutical Business Performance,' appears in the current issue of the Journal of Medical Marketing.
View the full article
